跳至主要内容
临床试验/NCT00633425
NCT00633425已完成4 期

Continuous Glucose Monitoring System (CGMS) in Type 2 Diabetic Patients Inadequately Controlled by Metformine Monotherapy; Analyze of Glycemic Profile Before and After Association of Glimepiride

Sanofi1 个研究点 分布在 1 个国家目标入组 43 人开始时间: 2002年10月1日最近更新:
适应症
相关药物

试验速览

阶段
4 期
状态
已完成
发起方
Sanofi
入组人数
43
试验地点
1
主要终点
Change in interstitial glucose levels between the observation and maintenance phases.

研究概览

简要总结

Analyse the glucose profile, based on continuous glucose monitoring by CGMS, in type 2 diabetics inadequately controlled by metformin, before and after the addition of Glimepiride.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
35 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Men or women aged 35 to 70 years
  • Having given their consent
  • Type 2 diabetics (HBA1c greater than 6.5%
  • Fasting glycaemia greater than 1.40 g/l) not controlled by Metformin for at least 6 weeks.

排除标准

  • 未提供

结局指标

主要结局

Change in interstitial glucose levels between the observation and maintenance phases.

时间窗: The mean of 24 variations in average hourly glucose readings recorded by CGMS.

次要结局

  • HbA1c and fasting blood glucose levels.(Measured in the observation and maintenance phases, and change between the two phases.)

研究者

发起方
Sanofi
申办方类型
Industry

研究点 (1)

Loading locations...

相似试验